Literature DB >> 1703134

Synthetic peptides to identify antigenic determinants on Epstein-Barr virus gp350/220.

G Bertoni1, D A Kostyal, P S Reisert, R E Humphreys, T Sairenji.   

Abstract

We synthesized three peptides, MA1 - Thr19-Val28(+Tyr) -, MA2 - Ser807-Ala816-, and MA3-Ser718-Glu729(+Tyr) from the sequence of Epstein-Barr virus gp350/220 and immunized rabbits with these peptides. Rabbit antisera to the peptides had antipeptide radioimmunoassay titers of 1:400 for anti-MA1, 1:200 for anti-MA2, and 1:1600 for anti-MA3. The anti-MA1 serum recognized gp350/220 in Western blotting to SDS-electrophoresed proteins from 12-O-tetradecanoylphorbol-13-acetate- and n-butyrate-treated B95-8 cells, but anti-MA2 and MA3 sera did not. None of the sera reacted with gp350/220 by membrane or cytoplasmic immunofluorescence or by immunoprecipitation of Triton X-100 solubilized proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703134     DOI: 10.1159/000150164

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  2 in total

1.  Selection of antibody probes to correlate protein sequence domains with their structural distribution.

Authors:  M Valle; M Muñoz; L Kremer; J M Valpuesta; C Martínez-A; J L Carrascosa; J P Albar
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Pepscan Approach for the Identification of Protein-Protein Interfaces: Lessons from Experiment.

Authors:  Angelita Rebollo; Eric Savier; Pierre Tuffery
Journal:  Biomolecules       Date:  2021-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.